Literature DB >> 2085097

Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles.

W Paulus1, M Selim.   

Abstract

A man, aged 58 years, suffered from progressive dementia, parkinsonism, and gaze paralysis for 30 months. Autopsy revealed severe degeneration of the substantia nigra, numerous swollen chromatolytic neurons within the cerebral cortex, scattered basal neurofibrillary tangles, and gliosis of the cerebral white matter and basal ganglia. Unusual globular inclusions positive for tau protein were detected within neurons of the upper cortical layers. Although the pathological findings were comparable with corticonigral degeneration with neuronal achromasia, several clinical and pathological features characteristic for progressive supranuclear palsy, progressive subcortical gliosis, and Pick's disease in this and the nine previously reported cases hampered the unequivocal nosological placement.

Entities:  

Mesh:

Year:  1990        PMID: 2085097     DOI: 10.1007/BF00662643

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  35 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

2.  Pick bodies in the locus ceruleus.

Authors:  L S Forno; L F Eng; D J Selkoe
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles.

Authors:  C Bancher; H Lassmann; H Budka; I Grundke-Iqbal; K Iqbal; G Wiche; F Seitelberger; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  [Presenile glial dystrophy].

Authors:  F Seitelberger
Journal:  Acta Neuropathol       Date:  1968       Impact factor: 17.088

5.  Focal accumulation of phosphorylated neurofilaments within anterior horn cell in familial amyotrophic lateral sclerosis.

Authors:  H Mizusawa; S Matsumoto; S H Yen; A Hirano; R R Rojas-Corona; H Donnenfeld
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  A case of progressive supranuclear palsy with fibrillary gliosis of the midbrain and pontine reticular formation.

Authors:  H Ishino; T Sasaki; K Yamashita; H Senô; H Kodaka; J Yoshinaga; H Ideshita; T Yamanaka; A Hikiji
Journal:  Clin Neuropathol       Date:  1987 Mar-Apr       Impact factor: 1.368

7.  Corticodentatonigral degeneration with neuronal achromasia.

Authors:  J J Rebeiz; E H Kolodny; E P Richardson
Journal:  Arch Neurol       Date:  1968-01

8.  Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.

Authors:  D W Dickson; H Crystal; L A Mattiace; Y Kress; A Schwagerl; H Ksiezak-Reding; P Davies; S H Yen
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  Thalamic and subcortical gliosis with dementia.

Authors:  J Moossy; A J Martinez; I Hanin; G Rao; H Yonas; F Boller
Journal:  Arch Neurol       Date:  1987-05

Review 10.  Progressive supranuclear palsy. Clinical and pharmacologic update.

Authors:  J Jankovic
Journal:  Neurol Clin       Date:  1984-08       Impact factor: 3.806

View more
  26 in total

1.  Corticobasal Degeneration.

Authors:  Panida Piboolnurak; Cheryl H. Waters
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

2.  Relationships between Lewy bodies and pale bodies in Parkinson's disease.

Authors:  G E Dale; A Probst; P Luthert; J Martin; B H Anderton; P N Leigh
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Differential incorporation of tau isoforms in Alzheimer's disease.

Authors:  Marisol Espinoza; Rohan de Silva; Dennis W Dickson; Peter Davies
Journal:  J Alzheimers Dis       Date:  2008-05       Impact factor: 4.472

4.  Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.

Authors:  Canan Ozsancak; Pascal Auzou; Kathy Dujardin; Niall Quinn; Alain Destée
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

5.  Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments.

Authors:  M G Spillantini; M Goedert; R A Crowther; J R Murrell; M R Farlow; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

6.  Tau Protein and Frontotemporal Dementias.

Authors:  Michel Goedert; Maria Grazia Spillantini; Benjamin Falcon; Wenjuan Zhang; Kathy L Newell; Masato Hasegawa; Sjors H W Scheres; Bernardino Ghetti
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Unusual case of corticobasal degeneration with tau/Gallyas-positive neuronal and glial tangles.

Authors:  D S Horoupian; P L Chu
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Discrepancy between clinical and pathological diagnoses of CBD and PSP.

Authors:  Toshiki Mizuno; Kensuke Shiga; Yuriko Nakata; Junko Nagura; Taizen Nakase; Yoshihiro Ueda; Yoshiaki Takanashi; Kohji Urasaki; Yumiko Oyamada; Shinji Fushiki; Junji Nishikawa; Masahiro Yasuhara; Kenji Nakajima; Masanori Nakagawa
Journal:  J Neurol       Date:  2005-03-09       Impact factor: 4.849

9.  Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations.

Authors:  K Wakabayashi; K Oyanagi; T Makifuchi; F Ikuta; A Homma; Y Homma; Y Horikawa; S Tokiguchi
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration.

Authors:  H Ksiezak-Reding; K Morgan; L A Mattiace; P Davies; W K Liu; S H Yen; K Weidenheim; D W Dickson
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.